Susan H. Eshleman - Publications

Affiliations: 
Cellular and Molecular Medicine Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Area:
HIV
Website:
http://cmm.jhu.edu/index.php?title=Susan_H._Eshleman

150 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, ... Eshleman SH, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England Journal of Medicine. PMID 27424812 DOI: 10.1056/NEJMoa1600693  0.68
2016 Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, ... ... Eshleman SH, et al. CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. Hiv Clinical Trials. 1-7. PMID 27300696 DOI: 10.1080/15284336.2016.1180771  0.68
2016 Agwu AL, Yao TJ, Eshleman SH, Patel K, Huang W, Burchett SK, Siberry GK, Van Dyke RB. Phenotypic Co-receptor Tropism in Perinatally HIV-Infected Youth Failing Antiretroviral Therapy. The Pediatric Infectious Disease Journal. PMID 27078121 DOI: 10.1097/INF.0000000000001158  0.68
2016 Kirkpatrick AR, Patel EU, Celum C, Moore R, Blankson J, Mehta S, Kirk G, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O. Development and Evaluation of a Modified Fourth Generation HIV Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. Aids Research and Human Retroviruses. PMID 26988426 DOI: 10.1089/AID.2015.0198  0.68
2016 Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, ... ... Eshleman SH, et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26859828 DOI: 10.1097/QAI.0000000000000951  0.68
2015 Chen I, Clarke W, Ou SS, Marzinke MA, Breaud A, Emel LM, Wang J, Hughes JP, Richardson P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SL, Eshleman SH. Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. Plos One. 10: e0140074. PMID 26445283 DOI: 10.1371/journal.pone.0140074  0.68
2015 Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE. Evaluation of postpartum HIV superinfection and mother-to-child transmission. Aids (London, England). 29: 1567-73. PMID 26244396 DOI: 10.1097/QAD.0000000000000740  0.68
2015 Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, ... ... Eshleman SH, et al. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. Plos Medicine. 12: e1001845. PMID 26030872 DOI: 10.1371/journal.pmed.1001845  0.68
2015 Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, ... ... Eshleman SH, et al. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 446-52. PMID 25861015 DOI: 10.1097/QAI.0000000000000633  0.68
2015 Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, ... ... Eshleman SH, et al. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. Plos Medicine. 12: e1001810. PMID 25849352 DOI: 10.1371/journal.pmed.1001810  0.68
2015 Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, ... Eshleman SH, et al. Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 430-8. PMID 25835607 DOI: 10.1097/QAI.0000000000000610  0.68
2015 Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. The Journal of Infectious Diseases. PMID 25712973 DOI: 10.1093/infdis/jiv110  0.68
2015 Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, ... ... Eshleman SH, et al. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1541-9. PMID 25681380 DOI: 10.1093/cid/civ102  0.68
2015 Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 62: 75-9. PMID 25542477 DOI: 10.1016/j.jcv.2014.11.023  0.68
2015 Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O. Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. Aids Research and Human Retroviruses. 31: 421-7. PMID 25317854 DOI: 10.1089/AID.2014.0081  0.68
2014 Lindsey JC, Hughes MD, Violari A, Eshleman SH, Abrams EJ, Bwakura-Dangarembizi M, Barlow-Mosha L, Kamthunzi P, Sambo PM, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Zimmer B, et al. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission. The Pediatric Infectious Disease Journal. 33: 846-54. PMID 25222305 DOI: 10.1097/INF.0000000000000337  0.68
2014 Mannheimer SB, Wang L, Wilton L, Van Tieu H, Del Rio C, Buchbinder S, Fields S, Glick S, Connor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH. Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 438-45. PMID 25197830 DOI: 10.1097/QAI.0000000000000334  0.68
2014 Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, ... Eshleman SH, et al. Low-level Viremia early in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 405-8. PMID 25140905 DOI: 10.1097/QAI.0000000000000298  0.68
2014 Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, ... ... Eshleman SH, et al. Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. The Lancet. Global Health. 2: e267-77. PMID 25103167 DOI: 10.1016/S2214-109X(14)70032-4  0.68
2014 Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, ... ... Eshleman SH, et al. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. Plos One. 9: e101043. PMID 24968135 DOI: 10.1371/journal.pone.0101043  0.68
2014 Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Mannheimer S, Del Rio C, Kuo I, ... ... Eshleman SH, et al. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. Hiv Clinical Trials. 15: 62-8. PMID 24710920 DOI: 10.1310/hct1502-62  0.68
2014 Marzinke MA, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W. The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clinica Chimica Acta; International Journal of Clinical Chemistry. 433: 157-68. PMID 24661980 DOI: 10.1016/j.cca.2014.03.016  0.68
2014 Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, ... ... Eshleman SH, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. The Lancet. Infectious Diseases. 14: 281-90. PMID 24602844 DOI: 10.1016/S1473-3099(13)70692-3  0.68
2014 Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 390-6. PMID 24583613 DOI: 10.1097/QAI.0000000000000006  0.68
2014 Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. Aids (London, England). 28: 1227-32. PMID 24513567 DOI: 10.1097/QAD.0000000000000221  0.68
2014 Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, et al. Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. Plos One. 9: e87298. PMID 24498067 DOI: 10.1371/journal.pone.0087298  0.68
2014 Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, ... ... Eshleman SH, et al. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 366-74. PMID 24189151 DOI: 10.1097/QAI.0000000000000052  0.68
2014 Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, ... ... Eshleman SH, et al. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. Journal of Clinical Microbiology. 52: 115-21. PMID 24153134 DOI: 10.1128/JCM.02040-13  0.68
2014 Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, ... ... Eshleman SH, et al. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 117-20. PMID 24092804 DOI: 10.1093/cid/cit672  0.68
2014 Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. Aids Research and Human Retroviruses. 30: 339-44. PMID 24083837 DOI: 10.1089/AID.2013.0169  0.68
2014 Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, et al. Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 33-41. PMID 23979002 DOI: 10.1097/QAI.0b013e3182a921eb  0.68
2014 Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Paquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds SJ, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, et al. HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression. The Journal of Infectious Diseases. 209: 66-73. PMID 23922373 DOI: 10.1093/infdis/jit425  0.68
2013 Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, ... ... Eshleman SH, et al. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. Plos One. 8: e82772. PMID 24386116 DOI: 10.1371/journal.pone.0082772  0.68
2013 Chen I, Khaki L, Lindsey JC, Fry C, Cousins MM, Siliciano RF, Violari A, Palumbo P, Eshleman SH. Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children. Plos One. 8: e81213. PMID 24312277 DOI: 10.1371/journal.pone.0081213  0.68
2013 Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, ... ... Eshleman SH, et al. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. Plos One. 8: e78818. PMID 24236054 DOI: 10.1371/journal.pone.0078818  0.68
2013 Ping LH, Jabara CB, Rodrigo AG, Hudelson SE, Piwowar-Manning E, Wang L, Eshleman SH, Cohen MS, Swanstrom R. HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. Plos One. 8: e71557. PMID 24086252 DOI: 10.1371/journal.pone.0071557  0.68
2013 Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, et al. Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. Plos One. 8: e70413. PMID 23922989 DOI: 10.1371/journal.pone.0070413  0.68
2013 Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, ... ... Eshleman SH, et al. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). The Journal of Infectious Diseases. 208: 1624-8. PMID 23908493 DOI: 10.1093/infdis/jit390  0.68
2013 Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J, Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, ... ... Eshleman SH, et al. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). Plos One. 8: e68349. PMID 23874597 DOI: 10.1371/journal.pone.0068349  0.68
2013 Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH. Cross-sectional HIV incidence estimation in HIV prevention research. Journal of Acquired Immune Deficiency Syndromes (1999). 63: S233-9. PMID 23764641 DOI: 10.1097/QAI.0b013e3182986fdf  0.68
2013 Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, ... ... Eshleman SH, et al. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. The Journal of Infectious Diseases. 207: S70-7. PMID 23687292 DOI: 10.1093/infdis/jit114  0.68
2013 Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda. Aids Research and Human Retroviruses. 29: 1146-50. PMID 23641870 DOI: 10.1089/AID.2012.0105  0.68
2013 James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH. Antibody maturation and viral diversification in HIV-infected women. Plos One. 8: e57350. PMID 23460842 DOI: 10.1371/journal.pone.0057350  0.68
2013 Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. Plos One. 8: e55525. PMID 23437058 DOI: 10.1371/journal.pone.0055525  0.68
2013 Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. Estimation of HIV incidence using multiple biomarkers. American Journal of Epidemiology. 177: 264-72. PMID 23302151 DOI: 10.1093/aje/kws436  0.68
2013 Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM, et al. HIV acquisition among women from selected areas of the United States: a cohort study. Annals of Internal Medicine. 158: 10-8. PMID 23277896 DOI: 10.7326/0003-4819-158-1-201301010-00004  0.68
2013 Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. The Pediatric Infectious Disease Journal. 32: e164-9. PMID 23249916 DOI: 10.1097/INF.0b013e31827f44ee  0.68
2013 Cousins MM, Donnell D, Eshleman SH. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. The Journal of Molecular Diagnostics : Jmd. 15: 130-7. PMID 23178437 DOI: 10.1016/j.jmoldx.2012.08.008  0.68
2013 Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, ... ... Eshleman SH, et al. HIV incidence determination in the United States: a multiassay approach. The Journal of Infectious Diseases. 207: 232-9. PMID 23129760 DOI: 10.1093/infdis/jis659  0.68
2013 Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J, Vallari AS, Justman J, Hodder S. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. The Journal of Infectious Diseases. 207: 223-31. PMID 23129758 DOI: 10.1093/infdis/jis658  0.68
2012 Cousins MM, Swan D, Magaret CA, Hoover DR, Eshleman SH. Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. Plos One. 7: e51359. PMID 23240016 DOI: 10.1371/journal.pone.0051359  0.68
2012 Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. Journal of Clinical Microbiology. 50: 3054-9. PMID 22785188 DOI: 10.1128/JCM.01460-12  0.68
2012 James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. The Pediatric Infectious Disease Journal. 31: e222-8. PMID 22785048 DOI: 10.1097/INF.0b013e3182678c3f  0.68
2012 Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, et al. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. The New England Journal of Medicine. 366: 2380-9. PMID 22716976 DOI: 10.1056/NEJMoa1113249  0.68
2012 Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M. Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 462-5. PMID 22614899 DOI: 10.1097/QAI.0b013e31825ddcfa  0.68
2012 Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH. Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. Aids Research and Human Retroviruses. 28: 1739-44. PMID 22443282 DOI: 10.1089/AID.2011.0352  0.68
2012 Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. Aids Research and Human Retroviruses. 28: 1177-83. PMID 22283149 DOI: 10.1089/AID.2011.0341  0.68
2012 Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, ... ... Eshleman SH, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet. 379: 221-8. PMID 22196945 DOI: 10.1016/S0140-6736(11)61653-X  0.68
2012 Beck IA, Jang M, McKernan-Mullin J, Bull M, Wagner T, Huang S, Song LY, Nachman S, Krogstad P, Eshleman SH, Wiznia A, Frenkel LM. Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. Aids Research and Human Retroviruses. 28: 780-8. PMID 22081867 DOI: 10.1089/AID.2011.0039  0.68
2012 Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. Aids Research and Human Retroviruses. 28: 816-22. PMID 22014036 DOI: 10.1089/AID.2011.0258  0.68
2012 Redd AD, Laeyendecker O, Kong X, Kiwanuka N, Lutalo T, Huang W, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC. Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression. Aids Research and Human Retroviruses. 28: 289-94. PMID 21663455 DOI: 10.1089/AID.2011.0006  0.68
2011 Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, ... ... Eshleman SH, et al. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. Plos One. 6: e27211. PMID 22073290 DOI: 10.1371/journal.pone.0027211  0.68
2011 Laeyendecker O, Latimore A, Eshleman SH, Summerton J, Oliver AE, Gamiel J, Dobbs T, Mei J, Murphy G, Parry JV, Owen SM, Quinn TC. The effect of sample handling on cross sectional HIV incidence testing results. Plos One. 6: e25899. PMID 22046249 DOI: 10.1371/journal.pone.0025899  0.68
2011 Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, Hosseinipour MC, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. The Journal of Infectious Diseases. 204: 1918-26. PMID 21990420 DOI: 10.1093/infdis/jir651  0.68
2011 Ziemniak C, Mengistu Y, Ruff A, Chen YH, Khaki L, Bedri A, Simen BB, Palumbo P, Eshleman SH, Persaud D. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings. Journal of Clinical Microbiology. 49: 4077-82. PMID 21956987 DOI: 10.1128/JCM.01004-11  0.68
2011 Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, ... ... Eshleman SH, et al. HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). Bmc Infectious Diseases. 11: 251. PMID 21943026 DOI: 10.1186/1471-2334-11-251  0.68
2011 Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, ... ... Eshleman SH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine. 365: 493-505. PMID 21767103 DOI: 10.1056/NEJMoa1105243  0.68
2011 Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofensen LM, Taylor A, Fowler MG, Kumenda NI, Eshleman SH. Association of recent HIV infection and in-utero HIV-1 transmission. Aids (London, England). 25: 1357-64. PMID 21572305 DOI: 10.1097/QAD.0b013e3283489d45  0.68
2011 James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH. Association of HIV diversity and survival in HIV-infected Ugandan infants. Plos One. 6: e18642. PMID 21533179 DOI: 10.1371/journal.pone.0018642  0.68
2011 Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis. Aids (London, England). 25: 911-7. PMID 21487249 DOI: 10.1097/QAD.0b013e328344fedc  0.68
2011 Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MC, Eshleman SH. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1069-76. PMID 21460326 DOI: 10.1093/cid/cir008  0.68
2010 Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, ... ... Eshleman SH, et al. Analysis of HIV tropism in Ugandan infants. Current Hiv Research. 8: 498-503. PMID 21073438  0.68
2010 Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH. Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. Plos One. 5: e13259. PMID 20949006 DOI: 10.1371/journal.pone.0013259  0.68
2010 Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. The New England Journal of Medicine. 363: 1510-20. PMID 20942667 DOI: 10.1056/NEJMoa1000931  0.68
2010 Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH. Analysis of HIV diversity using a high-resolution melting assay. Aids Research and Human Retroviruses. 26: 913-8. PMID 20666583 DOI: 10.1089/aid.2009.0259  0.68
2010 Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C. Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection. The Journal of Infectious Diseases. 202: 734-8. PMID 20649426 DOI: 10.1086/655662  0.68
2010 Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH. Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. Aids Research and Human Retroviruses. 26: 563-8. PMID 20455758 DOI: 10.1089/aid.2009.0164  0.68
2010 Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D, et al. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1041-52. PMID 20192725 DOI: 10.1086/651118  0.68
2010 Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S. One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. Aids Research and Human Retroviruses. 26: 25-31. PMID 20063995 DOI: 10.1089/aid.2009.0102  0.68
2010 Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. Aids (London, England). 24: 557-61. PMID 20057308 DOI: 10.1097/QAD.0b013e3283346e60  0.68
2010 Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. Aids (London, England). 24: 381-6. PMID 19996936 DOI: 10.1097/QAD.0b013e3283352ef1  0.68
2009 Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ. Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. Aids Research and Human Retroviruses. 25: 795-802. PMID 19678765 DOI: 10.1089/aid.2008.0252  0.68
2009 Church JD, Huang W, Parkin N, Marlowe N, Guay LA, Omer SB, Musoke P, Jackson JB, Eshleman SH. Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. Aids Research and Human Retroviruses. 25: 657-63. PMID 19621988 DOI: 10.1089/aid.2008.0235  0.68
2009 Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke PM, Jackson JB, Guay LA. Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 32-9. PMID 19617849 DOI: 10.1097/QAI.0b013e3181afd352  0.68
2009 Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Archives of Internal Medicine. 169: 1224-32. PMID 19597072 DOI: 10.1001/archinternmed.2009.172  0.68
2009 Huang W, Eshleman SH, Toma J, Stawiski E, Whitcomb JM, Jackson JB, Guay L, Musoke P, Parkin N, Petropoulos CJ. Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs. Aids (London, England). 23: 1903-8. PMID 19593079 DOI: 10.1097/QAD.0b013e32832f1802  0.68
2009 Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, ... Eshleman SH, et al. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. Aids Research and Human Retroviruses. 25: 673-7. PMID 19552593 DOI: 10.1089/aid.2009.0003  0.68
2009 Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B, Eshleman SH. Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. Aids Research and Human Retroviruses. 25: 701-5. PMID 19552592 DOI: 10.1089/aid.2009.0014  0.68
2009 Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, Husnik M, Koblin B, Coates T, Chesney M, Vallari A, Devare SG, Hackett J. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 121-4. PMID 19506484 DOI: 10.1097/QAI.0b013e3181ab61e1  0.68
2009 Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. The Journal of Infectious Diseases. 199: 1301-9. PMID 19338474 DOI: 10.1086/597759  0.68
2009 Eshleman SH, Hudelson SE, Smith P, Hackett J, Holzmayer V, Swanson P, Devare SG, Marlowe N. Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. Aids Research and Human Retroviruses. 25: 343-5. PMID 19327053 DOI: 10.1089/aid.2008.0236  0.68
2009 Eshleman SH, Laeyendecker O, Parkin N, Huang W, Chappey C, Paquet AC, Serwadda D, Reynolds SJ, Kiwanuka N, Quinn TC, Gray R, Wawer M. Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. Aids (London, England). 23: 845-52. PMID 19276794 DOI: 10.1097/QAD.0b013e328327957a  0.68
2009 Church JD, Eshleman SH. Reply to Krivine et al. Journal of Infectious Diseases. 199: 1554-1555. DOI: 10.1086/598480  0.68
2008 Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH. Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). Aids Research and Human Retroviruses. 24: 1209-13. PMID 18788912 DOI: 10.1089/aid.2008.0109  0.68
2008 Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. The Journal of Infectious Diseases. 198: 1075-82. PMID 18684096 DOI: 10.1086/591503  0.68
2008 Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. The Journal of Infectious Diseases. 198: 465-9. PMID 18582198 DOI: 10.1086/590160  0.68
2008 Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. Hiv Clinical Trials. 9: 91-102. PMID 18474494 DOI: 10.1310/hct0902-91  0.68
2008 Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH. HIV-1 tropism and survival in vertically infected Ugandan infants. The Journal of Infectious Diseases. 197: 1382-8. PMID 18444795 DOI: 10.1086/587492  0.68
2008 Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH. Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. Aids Research and Human Retroviruses. 24: 595-605. PMID 18370589 DOI: 10.1089/aid.2007.0224  0.68
2007 Eshleman SH, Hudelson SE, Bruce R, Lee T, Owens MR, Hackett J, Swanson P, Devare SG, Marlowe N. Analysis of HIV type 1 gp41 sequences in diverse HIV type 1 strains. Aids Research and Human Retroviruses. 23: 1593-8. PMID 18160019 DOI: 10.1089/aid.2007.0130  0.68
2007 Flys TS, Mwatha A, Guay LA, Nakabiito C, Donnell D, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine. Aids (London, England). 21: 2077-82. PMID 17885298 DOI: 10.1097/QAD.0b013e3282703847  0.68
2007 McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, Eshleman SH. Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter? American Journal of Obstetrics and Gynecology. 197: S56-63. PMID 17825651 DOI: 10.1016/j.ajog.2007.02.031  0.68
2007 Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH. HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. Aids Research and Human Retroviruses. 23: 764-8. PMID 17604538 DOI: 10.1089/aid.2006.0272  0.68
2007 Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. Journal of Virology. 81: 7885-93. PMID 17507467 DOI: 10.1128/JVI.00218-07  0.68
2007 Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, Huang W, Hart S, Jackson B, Coates T, Chesney M, Koblin B. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. Aids (London, England). 21: 1165-74. PMID 17502727 DOI: 10.1097/QAD.0b013e32810fd72e  0.68
2007 Flys TS, Donnell D, Mwatha A, Nakabiito C, Musoke P, Mmiro F, Jackson JB, Guay LA, Eshleman SH. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. The Journal of Infectious Diseases. 195: 711-5. PMID 17262714 DOI: 10.1086/511433  0.68
2006 Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. The Journal of Molecular Diagnostics : Jmd. 8: 430-2; quiz 527. PMID 16931582 DOI: 10.2353/jmoldx.2006.050148  0.68
2006 Eshleman SH, Church JD, Chen S, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Hoover DR. Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 518-21. PMID 16810119 DOI: 10.1097/01.qai.0000221676.22069.b8  0.68
2006 Flys TS, Chen S, Jones DC, Hoover DR, Church JD, Fiscus SA, Mwatha A, Guay LA, Mmiro F, Musoke P, Kumwenda N, Taha TE, Jackson JB, Eshleman SH. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 610-3. PMID 16773030 DOI: 10.1097/01.qai.0000221686.67810.20  0.68
2006 Eshleman SH, Lie Y, Hoover DR, Chen S, Hudelson SE, Fiscus SA, Petropoulos CJ, Kumwenda N, Parkin N, Taha TE. Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women. The Journal of Infectious Diseases. 193: 1512-5. PMID 16652278 DOI: 10.1086/503810  0.68
2006 Eshleman SH, Jones D, Galovich J, Paxinos EE, Petropoulos CJ, Jackson JB, Parkin N. Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations. Aids Research and Human Retroviruses. 22: 289-93. PMID 16545016 DOI: 10.1089/aid.2006.22.289  0.68
2006 Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Mâsse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. Aids (London, England). 20: 543-51. PMID 16470118 DOI: 10.1097/01.aids.0000210608.70762.c3  0.68
2006 Eshleman SH, Hoover DR, Hudelson SE, Chen S, Fiscus SA, Piwowar-Manning E, Jackson JB, Kumwenda NI, Taha TE. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1 Journal of Infectious Diseases. 193: 479-481. PMID 16425125 DOI: 10.1086/499967  0.68
2005 Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns. Aids (London, England). 19: 2167-9. PMID 16284468  0.68
2005 Flys T, Marlowe N, Hackett J, Parkin N, Schumaker M, Holzmayer V, Hay P, Eshleman SH. Analysis of PTAP duplications in the gag p6 region of subtype C HIV type 1. Aids Research and Human Retroviruses. 21: 739-41. PMID 16131315 DOI: 10.1089/aid.2005.21.739  0.68
2005 Eshleman SH, Guay LA, Wang J, Mwatha A, Brown ER, Musoke P, Mmiro F, Jackson JB. Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 24-9. PMID 16123677 DOI: 10.1097/01.qai.0000174656.71276.d6  0.68
2005 Eshleman SH, Guay LA, Mwatha A, Brown E, Musoke P, Mmiro F, Jackson JB. Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 593-7. PMID 16044013  0.68
2005 Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. Aids Research and Human Retroviruses. 21: 319-24. PMID 15943576 DOI: 10.1089/aid.2005.21.319  0.68
2005 Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. The Journal of Infectious Diseases. 192: 30-6. PMID 15942891 DOI: 10.1086/430764  0.68
2005 Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH. Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. The Journal of Infectious Diseases. 192: 24-9. PMID 15942890 DOI: 10.1086/430742  0.68
2005 Eshleman SH, Crutcher G, Petrauskene O, Kunstman K, Cunningham SP, Trevino C, Davis C, Kennedy J, Fairman J, Foley B, Kop J. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer. Journal of Clinical Microbiology. 43: 813-7. PMID 15695685 DOI: 10.1128/JCM.43.2.813-817.2005  0.68
2005 Kashuba AD, Tierney C, Downey GF, Acosta EP, Vergis EN, Klingman K, Mellors JW, Eshleman SH, Scott TR, Collier AC. Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results. Aids (London, England). 19: 145-52. PMID 15668539  0.68
2005 Eshleman SH, Hudelson SE, Gupta A, Bollinger R, Divekar AD, Gangakhedkar RR, Kulkarni SS, Thakar MR, Paranjape RS, Tripathy S. Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. Aids Research and Human Retroviruses. 21: 93-7. PMID 15665648 DOI: 10.1089/aid.2005.21.93  0.68
2004 Shi C, Eshleman SH, Jones D, Fukushima N, Hua L, Parker AR, Yeo CJ, Hruban RH, Goggins MG, Eshleman JR. LigAmp for sensitive detection of single-nucleotide differences. Nature Methods. 1: 141-7. PMID 15782177 DOI: 10.1038/nmeth713  0.68
2004 Marlowe N, Flys T, Hackett J, Schumaker M, Jackson JB, Eshleman SH. Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains. Aids Research and Human Retroviruses. 20: 1119-25. PMID 15585104 DOI: 10.1089/aid.2004.20.1119  0.68
2004 Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA. HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 552-8. PMID 15356820 DOI: 10.1086/422518  0.68
2004 Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB. Comparison of nevirapine (NVP) resistance in ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 Aids Research and Human Retroviruses. 20: 595-599. PMID 15242535 DOI: 10.1089/0889222041217518  0.68
2004 Eshleman SH, Hackett J, Swanson P, Cunningham SP, Drews B, Brennan C, Devare SG, Zekeng L, Kaptué L, Marlowe N. Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains Journal of Clinical Microbiology. 42: 2711-2717. PMID 15184457 DOI: 10.1128/JCM.42.6.2711-2717.2004  0.68
2004 Eshleman SH, Guay LA, Mwatha A, Brown ER, Cunningham SP, Musoke P, Mmiro F, Jackson JB. Characterization of Nevirapine Resistance Mutations in Women with Subtype A Vs. D HIV-1 6-8 Weeks after Single-Dose Nevirapine (HIVNET 012) Journal of Acquired Immune Deficiency Syndromes. 35: 126-130. PMID 14722443 DOI: 10.1097/00126334-200402010-00004  0.68
2003 Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, et al. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 482-90. PMID 14657758 DOI: 10.1097/00126334-200312150-00006  0.68
2003 Eshleman SH, Jones D, Flys T, Petrauskene O, Jackson JB. Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq™ HIV-1 Genotyping System Biotechniques. 35: 614-622. PMID 14513567  0.68
2003 Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JW. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping Journal of Clinical Microbiology. 41: 3265-3272. PMID 12843074 DOI: 10.1128/JCM.41.7.3265-3272.2003  0.68
2002 Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G, Musoke P, Mmiro F, Jackson JB. Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) Journal of Acquired Immune Deficiency Syndromes. 31: 327-330. PMID 12439209  0.68
2002 Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang L, Jackson JB, Eshleman SH. Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda. Aids Research and Human Retroviruses. 18: 791-6. PMID 12167271 DOI: 10.1089/08892220260139530  0.68
2002 Eshleman SH, Jackson JB. Nevirapine resistance after single dose prophylaxis Aids Reviews. 4: 59-63. PMID 12152519  0.68
2002 Eshleman SH, Gonzales MJ, Becker-Pergola G, Cunningham SC, Guay LA, Jackson JB, Shafer RW. Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. Aids Research and Human Retroviruses. 18: 507-11. PMID 12015904 DOI: 10.1089/088922202317406655  0.68
2002 Krogstad P, Nachman S, Palumbo P, Eshleman SH, Geng Y, Jackson JB, Wantman M, Korber B, Lang D, Wiznia A, Johnson G. Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1 Aids Research and Human Retroviruses. 18: 413-417. PMID 11958684 DOI: 10.1089/088922202753614173  0.68
2001 Mracna M, Becker-Pergola G, Dileanis J, Guay LA, Cunningham S, Jackson JB, Eshleman SH. Performance of applied biosystems ViroSeq HIV-1 genotyping system for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda Journal of Clinical Microbiology. 39: 4323-4327. PMID 11724839 DOI: 10.1128/JCM.39.12.4323-4327.2001  0.68
2001 Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Fowler MG, Mofenson LM, Mmiro F, Jackson JB. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) Aids. 15: 1951-1957. PMID 11600822 DOI: 10.1097/00002030-200110190-00006  0.68
2001 Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study) Journal of Infectious Diseases. 184: 914-917. PMID 11509999 DOI: 10.1086/323153  0.68
2001 Eshleman SH, Krogstad P, Brooks Jackson J, Wang YG, Lee S, Wei LJ, Cunningham S, Wantman M, Wiznia A, Johnson G, Nachman S, Palumbo P. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) Journal of Infectious Diseases. 183: 1732-1738. PMID 11372025 DOI: 10.1086/320728  0.68
2001 Cunningham S, Ank B, Lewis D, Lu W, Wantman M, Dileanis J, Jackson JB, Palumbo P, Krogstad P, Eshleman SH. Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) Genotyping System for sequence-based analysis of HIV-1 in pediatric plasma samples Journal of Clinical Microbiology. 39: 1254-1257. PMID 11283037 DOI: 10.1128/JCM.39.4.1254-1257.2001  0.68
2000 Raines CP, Flexner C, Sun E, Heath-Chiozzi M, Lewis RH, Fields C, Deetz C, Apuzzo L, Eshleman SH, Jackson JB, Gallant JE. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes (1999). 25: 322-8. PMID 11114832  0.68
2000 Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission Aids. 14: F111-F115. PMID 10983633 DOI: 10.1097/00002030-200007280-00001  0.68
2000 Becker-Pergola G, Mellquist JL, Guay L, Mmiro F, Ndugwa C, Kataaha P, Jackson JB, Eshleman SH. Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women Aids Research and Human Retroviruses. 16: 1099-1104. PMID 10954884 DOI: 10.1089/088922200414938  0.68
2000 Weir EG, King KE, Ness PM, Eshleman SH. Automated RBC exchange transfusion:treatment for cerebral malaria. Transfusion. 40: 702-7. PMID 10864992 DOI: 10.1046/j.1537-2995.2000.40060702.x  0.68
2000 Becker-Pergola G, Kataaha P, Johnston-Dow L, Fung S, Jackson JB, Eshleman SH. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults Aids Research and Human Retroviruses. 16: 807-813. PMID 10826487 DOI: 10.1089/088922200308800  0.68
1999 Becker-Pergola G, Mellquist JL, Eshleman JR, Brooks Jackson J, Eshleman SH. Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: Relevance to studies of human immunodeficiency virus type 1 vertical transmission Molecular Diagnosis. 4: 261-268. PMID 10671637 DOI: 10.1016/S1084-8592(99)80001-0  0.68
1999 Mellquist JL, Becker-Pergola G, Gu J, Guay L, Himes L, Kataaha P, Mmiro F, Ndugwa C, Jackson JB, Eshleman SH. Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant Aids Research and Human Retroviruses. 15: 217-221. PMID 10029253 DOI: 10.1089/088922299311637  0.68
1998 Mellquist JL, Bowman B, Kasturi L, Guay L, Kataaha P, Mmiro F, Ndugwa C, Jackson JB, Eshleman SH. Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants Aids Research and Human Retroviruses. 14: 1391-1395. PMID 9788681  0.68
Show low-probability matches.